semaglutide cardiovascular outcomes study 2025 news effects on safety and in patients with overweight or obesity: a systematic review and meta-analysis Recent study finds that semaglutide

Accessto services, quality of care, and family impact for children with autism, other developmental disabilities, and other mental health conditions

Semaglutide also carries a boxed warning about thyroid C-cell tumors occurring in rodents (with unknown risk shown in humans)

Escalation of doses should be paused once grade 2 nausea or vomiting develops, as continued dose increases at this stage increases the risk of intolerance and discontinuation

Whether these prove clinically significant in the long term will depend on Phase 3 data

It is important to emphasize that speed is only helpful if the patient can maintain it